Acronyms and abbreviations
AASV ANCA-associated systemic vasculitis
AbMR antibody-mediated rejection
AChR acetylcholine receptor
ADEM acute disseminated encephalomyelitis
ADL activities of daily living
AHMC Australian Health Ministers’ Conference
AHMAC Australian Health Ministers’ Advisory Council
AIDS acquired immunodeficiency syndrome
AIHA autoimmune haemolytic anaemia
ALL acute lymphoblastic or lymphoid leukaemia
AML acute myeloid or myelogenous leukaemia
ANCA anti-neutrophil cytoplasmic antibody
ARCBS Australian Red Cross Blood Service (the Blood Service)
ARTG Australian Register of Therapeutic Goods
BP bullous pemphigoid
CIDP chronic inflammatory demyelinating polyneuropathy
CLL chronic lymphocytic leukemia
CP cicatricial pemphigoid
3 cerebrospinal fluid
CTEPC Clinical, Technical & Ethical Principal Committee of AHMAC
CVID common variable immunodeficiency DM dermatomyositis
DNA deoxyribonucleic acid
ESRD end-stage renal disease
FEIBA factor eight inhibitor bypassing agent
FIX clotting factor nine
FMAIT foeto-maternal alloimmune thrombocytopenia
FVIII clotting factor eight
g gram
GBS Guillain–Barré syndrome
GMP good manufacturing practice
HAART highly active anti-retroviral therapy
HDN haemolytic disease of the newborn
HIV human immunodeficiency virus
HLA human leukocyte antigen
HPA human platelet antigen
HSCT haemopoietic stem cell transplantation
IBM inclusion body myositis
Ig immunoglobulin
IgG immunoglobulin G
ITP immune/idiopathic thrombocytopenia purpura
IV intravenous
IVIg intravenous immunoglobulin
JBC Jurisdictional Blood Committee
JDO Jurisdictional Direct Order (for imported IVIg)
kg kilogram
L litre
LEMS Lambert–Eaton myasthenic syndrome
MAG myelin-associated glycoprotein
MG myasthenia gravis
MGUS monoclonal gammopathy of uncertain significance MM multiple myeloma
MMN multifocal motor neuropathy
MMP mucous membrane pemphigoid
MPO myeloperoxidase
MRC Medical Research Council
MRI magnetic resonance imaging
MS multiple sclerosis
n number
NAIT neonatal alloimmune thrombocytopenia
NBA National Blood Authority
NH neonatal haemochromatosis
NHL non-Hodgkin lymphoma
NHMRC National Health and Medical Research Council
NICRWG National IVIg Criteria Working Group
OMA opsoclonus myoclonus ataxia
PANDAS paediatric autoimmune neuropsychiatric disorder associated with streptococcal infections
PF pemphigus foliaceus
PICO population, intervention, comparator, outcome PID primary immunodeficiency
PM polymyositis
PPMS primary progressive multiple sclerosis
PRMS progressive relapsing multiple sclerosis
PTP post transfusion purpura
PV pemphigus vulgaris
RCT randomised controlled trial
RhD Rhesus D
RRMS relapsing remitting multiple sclerosis
SCLS systemic capillary leak syndrome
SCoH Standing Council on Health
SJS Stevens–Johnson syndrome
SLE systemic lupus erythematosus
SPMS secondary progressive multiple sclerosis
TEN toxic epidermal necrolysis
TGA Therapeutic Goods Administration
the Criteria Criteria for the clinical use of intravenous immunoglobulin in Australia
TSEAC Transmissible Spongiform Encephalopathies Advisory Committee
TSS toxic shock syndrome